← FDA DRUG APPROVALS

FDA ANDA · ANDA210273

MULTIPLE VITAMINS (ADULT) SINGLE DOSE

ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin 5-phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin

Sponsor: APOTEX

APPLICATION
ANDA210273
TYPE
ANDA
ORIGINAL APPROVAL
2026-04-09
LATEST ACTION
2026-04-09
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

MULTIPLE VITAMINS INJECTION ADULTPrescription
ALPHA-TOCOPHEROL ACETATE 2 IU/ML, ASCORBIC ACID 40MG/ML, BIOTIN 12MCG/ML, CHOLECALCIFEROL 40 IU/ML, CYANOCOBALAMIN 1MCG/ML, DEXPANTHENOL 3MG/ML, FOLIC ACID 120MCG/ML, NIACINAMIDE 8MG/ML, PYRIDOXINE HYDROCHLORIDE 1.2MG/ML, RIBOFLAVIN 5'-PHOSPHATE SODIUM 0.72MG/ML, THIAMINE HYDROCHLORIDE 1.2MG/ML, VITAMIN A PALMITATE 660 IU/ML, VITAMIN K 0.03MG/ML · SOLUTION · INTRAVENOUS

Approval history

2026-04-09UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →